OBJECTIVES: Describe the physical and psychological correlates of the Eating Inventory (EI) (also known as the Three-Factor Eating Questionnaire) factors in an obese sample, and determine the relationship between the three EI factors and weight loss. DESIGN: Consecutive series of obese women enrolled between 1987 and 1996 in clinical trials of weight loss treatments. PARTICIPANTS: 223 obese women with a weight of 100.7 AE 15.5 kg, an age of 41.4 AE 8.8 y and a body mass index (BMI) of 37.2 AE 5.6 kgam 2 . MEASURES: The EI and a variety of physical (weight, body composition and resting energy expenditure) and psychological (mood and binge eating) measures were assessed before and after 5 ± 6 months of treatment. RESULTS: Before treatment, higher restraint scores were associated with lower body weights (P 0.02), while higher disinhibition scores were associated with greater binge eating severity (P`0.0001). Weight loss treatment was associated with signi®cant increases in restraint and decreases in disinhibition and hunger (all Ps`0.0001). Greater increases in restraint during treatment were associated with larger weight losses (P`0.0001). CONCLUSIONS: The three factors of the EI showed clinical utility in a sample of women receiving treatment for obesity.
Introduction
It is a paradox that the construct of dietary restraint, introduced to explain the thoughts and behaviors of obese dieters, has been studied principally among persons of average weight. 1 ± 5 One of the principal instruments for assessing dietary restraint, as well as the constructs of disinhibition and hunger, is the Eating Inventory (EI) 6 (originally referred to as the Three-Factor Eating Questionnaire 7 ). Like the construct of dietary restraint, the EI has been assessed primarily among persons of average weight. 1,8 ± 14 These studies are of interest, but they reveal little about restraint, disinhibition and hunger, in persons for whom they have the most clinical relevanceÐ obese persons seeking weight loss treatment.
Only three studies have assessed the relationship between the EI and various constructs among obese persons seeking treatment. Two found that binge eating severity was associated with higher hunger and disinhibition scores, 15, 16 and the third found that higher energy intakes were associated with lower restraint scores, higher disinhibition scores and higher hunger scores. 17 Additional variables, such as body weight and resting energy expenditure (REE) have not been assessed for their relation to the EI factors in obese individuals, as they have in averageweight samples. 9, 11 Such studies are needed to assess the clinical utility of the EI factors among obese persons seeking treatment.
By contrast, at least nine studies have examined the relationship between the EI factors and weight loss. 18 ± 26 Given that most treatments for obesity are designed to increase restraint and decrease disinhibition, it is not surprising that weight loss treatments result in signi®cant increases in restraint and decreases in disinhibition. 18 ± 22 Although most studies have found no signi®cant relationship between initial EI scores and subsequent weight loss, 18,20 ± 22,26 changes in EI scores have shown a strong relationship with weight loss. 21, 22 Speci®cally, greater increases in restraint are associated with larger weight losses.
Although based on a relatively large number of studies, these ®ndings are less than conclusive, since almost half of the studies assessed EI factors either before or after weight loss. 23 ± 26 Among the ®ve studies that assessed both weight and EI scores over time, 18 ± 22 all had relatively small samples (n 26±60), and two did not directly assess the relationship (r values) between weight loss and change in EI scores. 19, 20 Furthermore, the generalizability of some ®ndings was limited by high attrition rates 19 and select treatments. 21 Since the EI is increasingly used in clinical and research settings, it is important to know its behavioral and biological correlates, as well as its relationship to weight loss among obese patients.
We administered the EI to a large consecutive series of obese women before and after weight loss. The study had three principal goals: 1) to provide normative information about the EI from a treatmentseeking obese sample; 2) to describe the physical and psychological correlates of the three EI factors in this sample; and 3) to determine the relationship between EI factors and weight loss.
Methods

Participants
Participants were a consecutive series of obese women, who were evaluated prior to enrollment in obesity treatment studies at the University of Pennsylvania's Weight and Eating Disorders Program between 1987 and 1996. These studies were controlled clinical trials of weight loss treatments that combined varying degrees of energy restriction with a comprehensive cognitive-behavioral treatment. 27 Three of the studies have been described previously 28 ± 30 and one began in March 1996. The initial treatment period for all studies was approximately six months. The studies included three dietary conditions: 1) a liquid based very-low calorie diet (VLCD) of 1674±3349 kJad (400±800 kcalad); 2) a portion controlled 3872 kJad (925 kcalad) diet that consisted of four liquid supplements, one portion-controlled dinner entree, one fruit serving and one cup of vegetable salad and 3) a self-selected 5023 kJad (1200 kcalad) diet of conventional foods. The ®rst two diets were consumed for 12±16 weeks, followed by a return to a self-selected diet of conventional foods. The third diet was consumed throughout the study period. All studies were approved by the University's Committee on Studies Involving Human Beings. Exclusion criteria for all investigations included:`130% of recommended weight; 31 a recent (within one year) myocardial infarction or evidence of any cardiac abnormalities; current (or history of) cerebrovascular, kidney, liver or thyroid disease; cancer; anemia; bulimia nervosa or any signi®cant psychiatric illness and Type I diabetes. Additional exclusions for the present study were smoking and medications known to affect weight or energy expenditure.
Among the 300 consecutive patients who were evaluated, 30 were smokers and 23 reported taking medications known to affect energy expenditure (for example, thyroid hormones, central nervous system (CNS) stimulants). Among the remaining 247, we were unable to obtain satisfactory resting energy expenditure (REE) measurements in 20 participants, six participants could not complete body composition assessments and pre-treatment EI data were not collected for six participants. Thus, of the original 300 patients, 223 were included in this study sample. (Note that some participants met more than one exclusion criteria.) Most (70%) of the participants were Caucasian, 28% African American, 1% Hispanic and 1% Native American.
Dependent measures
Participants were assessed on the following measures before treatment and 5±6 months later (range 18±24 weeks).
Weight. Body weight was measured to the nearest 0.1 kg and height to the nearest 0.6 cm with an attached vertical rod (Detecto Scale, Webb City, MO).
EI. Cognitions and behaviors associated with eating were assessed by the 51-item EI. 6 This three-factor scale assesses: cognitive restraint (conscious attempts to monitor and regulate intake); disinhibition (that is, dysregulation of eating in response to cognitive or emotional cues); and hunger (that is, perceptions of hunger). The scale consists of 36 trueafalse items and 15 forced-choice format questions. The restraint score is calculated from 21 items, disinhibition from 16 items and hunger from 14 items.
REE. REE was measured by indirect calorimetry (DeltaTrac Metabolic Monitor, SensorMedica, Yorba Linda, CA). Gas exchange (O 2 and CO 2 ) was measured (using a canopy collection technique) in the morning following an overnight fast and a rest period of 30 min, during which participants were in a semi-recumbent position. The detailed protocol for data collection and analysis has been reported previously. 32, 33 Body composition. Body composition was assessed by densitometry, as described by Goldman and Buskirk. 34 Underwater measurements were made six or more times until three readings within 25 g were obtained. Residual lung volume was measured by the oxygen dilution technique, 35 using a metabolic cart (MMC Horizon II, SensorMedics) with participants resting in the same position as they were underwater. Body density was calculated from the formula of Brozek et al 36 and percentage body fat from the formula of Siri.
37
Mood and binge eating. Mood was assessed by the 21-item Beck Depression Inventory (BDI). 38 Scores range from 0±63, with higher scores re¯ecting greater depressive symptomatology. Scores b15 suggest the need to evaluate further for the presence of clinically signi®cant depression. 38 Binge eating was assessed by the 16-time Binge Eating Scale (BES). 39 Scores range from 0±48 with higher scores re¯ecting a greater severity of binge eating. Scores of Eating Inventory in obese women GD Foster et al 0±17 `no disordered eating', 18±26 `moderate binge eating' and !27 `severe binge eating'. 15 
Statistical analyses
Pre-treatment. The relationship of the three EI factors (restraint, disinhibition and hunger) to various physical and psychological characteristics was assessed in two ways. First, participants were categorized into low, medium and high tertiles for each of the three EI factors. To avoid having participants with identical scores (on any one factor) being classi®ed in different tertiles, the number of participants in each tertile was not equal. Analysis of variance (ANOVA) was used to compare differences among the tertiles in age, body weight, body mass index (BMI), body composition, REE, mood and binge eating. Second, Pearson correlations were used to assess the linear relationship of restraint, disinhibition and hunger to the study's other measures.
Post-treatment. After 5±6 months of treatment, weight loss data were available for 205 participants. Due to a difference in study design, the EI was not administered to one cohort (n 59) of participants at follow-up. Thus, both weight loss and EI data were available for 146 participants. There were no signi®-cant differences between those who had follow-up data (n 146) and those who did not (n 77) on baseline measures of weight, BMI, restraint, disinhibition, hunger, mood or binge eating. Changes in weight and EI factors from baseline were examined by paired t-tests. The relationship of EI factors to weight loss was examined by ANCOVA, based on low, medium and high tertiles, and by correlational analyses. Values are presented as mean AE standard deviation (s.d.).
Results
The baseline characteristics of the 223 participants are presented in Table 1 The mean values for restraint, disinhibition and hunger were 8.2, 10.8 and 6.6, respectively (Table  1) . Restraint scores showed modest but signi®cant inverse relationships to disinhibition (r 70.22, P`0.001) and hunger scores (r 70.25, P0
.0001) ( Table 2 ). The strongest relationship among the three factors was that between disinhibition and hunger (r 0.48, P`0.0001) ( Table 3 ).
Relationship to physical characteristics
Restraint. Before treatment, higher restraint scores were associated with lower body weights and BMIs (Table 2) . Although the linear strength of these relationships was only modest (r values less than 0.2), an ANOVA revealed that participants with the highest restraint scores weighed 6.5 kg less than those with the lowest restraint scores (P 0.05). Similarly, those in the highest restraint group, had a mean BMI that was nearly 3 kgam 2 less than those in the lowest restraint group (P 0.007) ( Table 2) . Although restraint appeared to be associated with REE (r 70.16), this relationship was no longer signi®-cant when partial correlational analyses controlled for body weight or fat-free mass. Restraint scores were not signi®cantly related to age or percentage body fat.
Disinhibition. Higher disinhibition scores were weakly associated with higher body weights (r 0.13, P 0.06) and BMIs (r 0.16, P 0.02), but an ANOVA revealed no signi®cant differences in body weight or BMI among the disinhibition tertiles (Table 3) . Disinhibition scores were not signi®cantly related to age, percentage body fat or REE.
Hunger. Correlational analyses showed no signi®-cant relationship between hunger scores and percentage body fat (r 70.06) ( Table 4 ). An ANOVA, however, revealed that the medium tertile of participants had a higher percentage of body fat than did those in the high tertile (P 0.008), but the difference was only 3%. Hunger scores were not signi®cantly related to age, body weight, BMI or REE.
Relationship to psychological characteristics
Restraint. Restraint scores showed a signi®cant, inverse relationship to mood (r 70.18, P 0.008) Eating Inventory in obese women GD Foster et al Table 2) . Participants in the highest restraint group had signi®-cantly lower levels of dysphoria and binge eating, than did those in the low or medium tertiles. The difference in mean BDI scores (range of 7.5±10.9) was small, within the normal range and not clinically signi®cant. The difference in BES scores also lacked clinical signi®cance, placing high restraint participants (15.6) in the upper range of`no disordered eating' and low restraint participants (20.5) in the lower range of`moderate binge eating'.
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Disinhibition. Higher disinhibition scores were associated with increased dysphoria (r 0.47, P 0.0001) ( Table 3 ). Those in the highest disinhibition tertile had a mean BDI score of 12.5 compared to 6.0 in the lowest tertile; neither score met the criteria (score of 15) recommended for more intensive screening for depression. 38 Disinhibition was even more strongly related to binge eating (r 0.70, P 0.0001). The difference between the low and high disinhibition groups was clinically signi®cant with the low group (11.7) classi®ed as`no disordered eating' and the high group (24.6) at the upper range of`moderate binge eating'.
Hunger. Higher hunger scores were associated with higher BDI scores (r 0.32, P 0.0001) ( Table 4) . Those in the highest hunger tertile had signi®cantly higher BDI scores than either the low or medium tertiles. The BDI score in the highest hunger tertile (12.5), however, was not clinically signi®cant. There was a similar but stronger relationship between hunger and binge eating (r 0.46, P 0.0001) with each hunger tertile, from low to high respectively, scoring signi®cantly higher on the BES. The mean BES score of the highest hunger group (22.5) classi®ed them in the upper range of`moderate binge eating', while the lowest group (14.5) was classi®ed as`no disordered eating.'
Post-treatment
Changes in weight and EI factors. Participants lost 16.7AE 7.9 kg after 5±6 months of treatment (P`0.0001). This 16.5% reduction in body weight and 17.2% reduction in percentage body fat was accompanied by signi®cant changes in each of the three EI factors (see Figure 1 ). Restraint scores increased by 89.6% (8.1AE 4.2 to 15.3AE 3.3), disinhibition scores decreased by 19.4% (10.7 AE 3.0 to 8.6 AE 3.5), and hunger scores decreased by 18.7% (6.7AE 3.3 to 5.4 AE 3.5) (all P values`0.0001).
Relationship of initial EI scores to weight loss.
Among initial values, restraint showed a modest (r 70.15, P 0.03) relationship to weight loss (Table 5 ). ANCOVA (controlling for initial BMI, initial REE and treatment condition) revealed that those with the lowest restraint scores before treatment, lost 3 kg more during treatment than those with the highest scores (P 0.06), although both groups experienced signi®cant weight loss (18.2 and 15.1 kg, respectively). Neither initial disinhibition nor initial hunger scores were signi®cantly related to weight loss.
Change in EI factors. There was a signi®cant inverse relationship (r 70.29, P 0.0001) between changes in restraint and changes in body weight during treatment. As restraint increased, body weight decreased. ANCOVA revealed a similarly strong and clinically signi®cant relationship (Table 5) . Those in the highest tertile (increase of 11 to 16 in restraint) lost 17.7 kg, while those in the lowest tertile (increase of 4 to a decrease of 4 in restraint) lost 12.4 kg (P 0.04) (Figure 2 ). Decreases in disinhibition showed a weak positive relation to weight loss (r 0.17, P 0.04), but ANCOVA revealed no signi®cant differences in weight loss among the disinhibition tertiles. There was no linear relationship between changes in hunger and weight loss, but there was a trend (P 0.06) for participants in the medium tertile to lose slightly less weight.
A series of three regression analyses, with forced entry, was performed to identify the relative contributions of changes in the three EI factors to weight loss. As shown in Table 6 , each model entered BMI ®rst (to control for the signi®cant effects of initial BMI on weight loss) followed by the change in restraint (Model 1), the change in disinhibition (Model 2) and the change in hunger (Model 3). Each model subsequently entered changes in the remaining two EI factors. Model 1 showed that the change in restraint signi®cantly increased the variance in weight loss explained by BMI alone from 16% to 23% (P 0.0001). There was no signi®cant additional Figure 1 Restraint, disinhibition and hunger before and after a 16.5% weight loss in 146 obese women. All reductions were signi®cant at the P`0.0001 level.
Eating Inventory in obese women GD Foster et al effect for changes in disinhibition or hunger (Table 6 ). Model 2 revealed that the change in disinhibition slightly, but signi®cantly, increased the variance in weight loss explained by BMI alone from 16% to 19% (P 0.02). Adding the change in restraint to the model increased the explained variance to 24% (P 0.001), while the change in hunger had no signi®cant effect. Model 3 showed that the change in hunger did not signi®cantly increase the variance in weight loss explained by BMI alone. Thus, across the three models, the change in restraint was most strongly related to weight loss. The change in disinhibition explained a small amount of incremental variance above that explained by BMI (Model 2), but it had no signi®cant effect after accounting for the change in restraint (Models 1 and 3). The second ®nding of this study was evidence for the clinical utility of the EI factors among obese women undergoing weight loss treatment. The inverse relationship between restraint and weight andaor BMI before treatment, suggested that the restraint factor was a marker of relative weight among obese treatment-seeking women. This signi®cant relationship is worthy of note, since it occurred despite a relatively restricted range of body weights. Unlike ®ndings in average weight samples, 9,11 restraint was not related to REE, suggesting that the 6.5 kg difference in body weight between the high and low restraint groups was due to decreased intake, presumably facilitated by increased restraint.
The clinical utility of the disinhibition factor in this clinical sample, was supported by its strong relationship with binge eating severity (r 0.70), as had been found in earlier studies. 15, 16 Those in the highest disinhibition tertile had BES scores (24.6) which were clinically signi®cant. By contrast, restraint showed only a modest (inverse) relationship to binge eating. Future studies would bene®t from using other measures of binge eating, such as the Questionnaire on Eating and Weight Patterns 40 or the Eating Disorder Examination. 41 Further evidence of the clinical utility of the EI was its ability to detect changes with treatment. Participants' signi®cant increases in restraint (89.6%) were accompanied by signi®cant decreases in disinhibition (19.4%) and hunger (18.7%). It is unknown if these changes were the result of cognitive-behavioral treatment, weight loss or some combination.
Finally, this study provided normative EI data from a large clinical sample of obese subjects studied before and after weight loss. The EI scores before treatment were similar to those of previously reported smaller samples of obese patients before treatment. 17,19 ± 22 Compared to average-weight samples, our obese participants scored lower in restraint, and higher in disinhibition and hunger. 42 This study also provided information about the relationship among the three EI factors in an obese sample. Restraint was weakly but signi®cantly related to disinhibition (r 70.22) and hunger (r 70.26), while the strongest relationship was between hunger and disinhibition (r 0.48). These data are similar to those in the only other study 17 of EI intercorrelations in the obese seeking treatment (r of 70.28, 70.22 and 0.62, respectively). It is interesting to note that although restraint and disinhibition showed a modest correlation at baseline, the increase in restraint was clearly a stronger predictor of weight loss than the change in disinhibition.
There were at least two limitations to this study. The ®rst was that our assessment period (5±6 months) limited our ability to examine the long-term relationship between the EI and weight loss. Second, our study sample was limited to obese women and to treatment forms that combined energy restriction and a comprehensive program of cognitive-behavioral therapy. 27 It would be useful to know the clinical utility of the EI factors in obese men, and in other weight loss treatments, such as pharmacotherapy and surgery. Finally, although the original factor analyses of the EI included both obese and non-obese subjects, 6, 7 it might be interesting to assess whether the factor structure stays constant in a sample limited to obese persons seeking treatment.
Conclusion
In summary, the EI factors: 1) showed signi®cant relationships to body weight and binge eating before treatment; 2) were sensitive to changes produced by treatment and 3) showed a strong relationship to weight loss in a large sample of obese women undergoing weight loss treatment. These data suggest that the EI has clinical utility for the obese in treatment settings.
